Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease

NCT00100282 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PRAECIS Pharmaceuticals Inc.